BIAF Aset Agregat Perusahaan bioaffinitytech.com

This daily price chart for bioAffinity Technologies (BIAF) reflects total assets at 6.19, while the business navigates challenges regarding government screening and the validation of patent methodology accuracy. bioAffinity Technologies is implementing eco-standards into digital diagnostics to minimize laboratory emissions. Financial stability relies on a single highly specialized test, creating risks due to a lack of product portfolio diversification.

BIAF: Aset Agregat Perusahaan bioAffinity Technologies 28.04.2023 - 28.10.2026

bioaffinitytech.com - rincian analitis lan metrik utama (BIAF)

- rega lan prakiraan konsensus rega:

Bagan kutipan bioAffinity Technologies, Inc.|BIAF - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar bioAffinity Technologies, Inc.|BIAF - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham bioAffinity Technologies|BIAF - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku bioaffinitytech.com|BIAF - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Utang marang Modal bioAffinity Technologies|BIAF - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal bioAffinity Technologies, Inc.|BIAF - Gunggung utang perusahaan|Rasio utang marang aset resik bioAffinity Technologies, Inc.

Analisis kabeh metrik perusahaan:bioAffinity Technologies

For bioAffinity Technologies (BIAF), whose operations are exposed to global supply chain disruptions and patent disputes, monitoring total balance sheet assets becomes a key indicator of resilience. This metric, reverse-calculated via ROA, reflects the market consensus on the value of all company resources, reminding investors that expanding the tangible asset base in biotech requires time and may temporarily reduce capital efficiency.

Pesaing wigati

AVBP (ArriVent BioPharma, Inc) - Nilai Total Aset Perusahaan|Aset Agregat Perusahaan Lantern Pharma Inc|Aset Agregat Perusahaan eEFFECTOR Therapeutics, Inc. (EFTR)